FilingSEC EDGAR8-K
Pyxis Oncology Appoints Thomas Civik as CEO and Chairman of the Board
· SEC accepted
StageManagement Change
Filing content
Pyxis Oncology has appointed interim CEO Thomas Civik as its permanent CEO and Chairman of the Board. Additionally, John Flavin has transitioned to Lead Independent Director, and director Santhosh Palani has resigned.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…